Relevance of tumor boards for the inclusion of patients in oncological clinical trials.
Saved in:
| Title: | Relevance of tumor boards for the inclusion of patients in oncological clinical trials. |
|---|---|
| Authors: | Dapper H; Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. hendrik-dapper@gmx.de., Dantes M; Department of Radiation Oncology, Comprehensive Cancer Center Munich, University Hospital Munich, LMU Munich, Munich, Germany. mauricedantes@web.de., Herschbach P; Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Algül H; Comprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany., Heinemann V; Department of Medicine III, Comprehensive Cancer Center Munich, University Hospital Munich, LMU Munich, Munich, Germany. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Aug; Vol. 149 (10), pp. 7601-7608. Date of Electronic Publication: 2023 Mar 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1335 |
|---|---|
| DOI: | 10.1007/s00432-022-04559-0 |
